Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 9, Number 10—October 2003

Letter

Antimicrobial Drug-resistant Salmonella Typhimurium (Reply to Helms)

Suggested citation for this article

Read original article.

Read Helms' reply.

In Reply to Helms: In the article by Helms et al., Helms concludes that infections with Salmonella Typhimurium strains resistant to ampicillin, chloramphenicol, streptomycin, sulfonamide, and tetracycline (hereafter referred to as penta-resistant) were associated with higher death rates than infections with non–penta-resistant S. Typhimurium. Helms also concluded that infections with quinolone-resistant (nalidixine-resistant) S. Typhimurium were associated with higher death rates than quinolone-susceptible S. Typhimurium (1).

Table 2 in Helms’ article provides information that enables close scrutiny of this conclusion and comparison of the excess mortality associated with penta-resistant, quinolone-susceptible S. Typhimurium with the excess mortality of non–penta-resistant S. Typhimurium (1). In this letter, the Table is based on the original table. However, two additional comparisons have been added: the p values, which are not based on the data but are approximations based on the parameters in the table.

The conclusion is that only quinolone resistance is associated with excess mortality compared with nonresistant isolates. Penta-resistant, quinolone-susceptible S. Typhimurium has a risk ratio of 2.9 (1.1 to 7.9) compared to the ratio of non–penta-resistant isolates 2.1 (1.5 to 2.9). When these figures are compared, the approximate p value is 0.55, which, of course, is far from being significant. Thus, on the basis of the article by Helms, penta resistance may not pose a greater threat to human health than non–penta resistance. However, the measured effect of penta resistance is achieved by the inclusion of quinolone-resistant S. Typhimurium in the group.

Jan Dahl*Comments to Author 
Author affiliation: *Danish Bacon and Meat Council, Copenhagen, Denmark

References

  1. Helms M, Vastrup P, Gerner-Smidt P, Mølbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis. 2002;8:4905.PubMed

Table

Suggested citation for this article: Dahl J. Antimicrobial drug-resistant Salmonella Typhimurium (reply to Helms). Emerg Infect Dis [serial online] 2003 Oct [date cited]. Available from: URL: http://wwwnc.cdc.gov/eid/article/9/10/02-0716.htm

DOI: 10.3201/eid0910.020716

Related Links

Top of Page

Table of Contents – Volume 9, Number 10—October 2003

Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Jan Dahl, Danish Bacon and Meat Council, Axeltory 3, 1609 Copenhagen V, Denmark; fax: 4533145756





characters(s) remaining.

Comment submitted successfully, thank you for your feedback.

Comments to the EID Editors

Please contact the EID Editors via our Contact Form.

 

Past Issues

Select a Past Issue:

World Malaria Day - April 25, 2014 - Invest in the future, defeat malaria

20th Anniversary - National Infant Immunization Week - Immunization. Power to Protect.

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO